Inc (NASDAQ:HUGE) (CSE:HUGE.CN) CEO Raza Bokhari tells Proactive how the firm is planning to use its recently-raised C$10.125 million. Bokhari says the Cobourg, Ontario-headquartered company had struck agreements with institutional investors for the purchase and sale of 1.5 million of its shares at C$6.75 each.
What's more, Bokhari explains how the company is progressing with submitting an IND application to the FDA for its coronavirus treatment.
CSE:HUGE
Market: CSE
Market Cap: $57.41 m
Follow
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of FSD Pharma named herein, including the promotion by the Company of FSD Pharma in any Content on the Site, the Company receives from said issuer...
FOR OUR FULL DISCLAIMER CLICK HEREDeep dive
FSD Pharma is building a mammoth hydroponic indoor cannabis production...
Most read
Full interview: FSD Pharma 'thrilled' to begin Phase 1 studies of its...
FSD Pharma Inc (NASDAQ:HUGE) (CSE:HUGE) BioSciences Division President Dr Ed Brennan tells Proactive the company has begun a Phase 1 human study of its anti-inflammatory ultra-micronized-palmitoylethanolamide (PEA) after winning approval from the Ethics Committee of the Alfred Hospital in...
on 03/11/2020
2 min read
Prev article
2 min read
